Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 23, 2017 16:01 ET | Source: Radius Health Inc.

Radius Health Reports Fourth Quarter and Full Year 2016 Financial and Operating Results

US FDA PDUFA for abaloparatide-SC is March 30, 2017 Build out of Commercial Organization to be completed in 1Q 2017 24-month ACTIVExtend trial has concluded, Radius to report top-line results in...
February 01, 2017 08:28 ET | Source: Radius Health Inc.

Mayo Clinic Proceedings Publishes Positive Results from the ACTIVExtend Clinical Trial of Abaloparatide-SC in Postmenopausal Women With Osteoporosis

– Results from interim analysis of the ACTIVExtend study of postmenopausal women with osteoporosis treated for 18 months with investigational drug abaloparatide-SC in the ACTIVE trial who were...
January 31, 2017 07:00 ET | Source: Radius Health Inc.

Radius Health to Announce Fourth Quarter and Full Year 2016 Financial Results, Host Conference Call and Live Webcast on February 23, 2017

WALTHAM, Mass., Jan. 31, 2017 (GLOBE NEWSWIRE) -- Radius Health (Nasdaq:RDUS) announced today that it will release its fourth quarter and full year 2016 financial results on Thursday, February 23,...
January 06, 2017 08:39 ET | Source: Radius Health Inc.

Radius Health to Present at the 35th Annual J.P. Morgan Healthcare Conference

WALTHAM, Mass., Jan. 06, 2017 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq:RDUS), a science-driven biopharmaceutical company focused on developing innovative therapeutics in the areas of...
December 08, 2016 08:45 ET | Source: Radius Health Inc.

Radius Presents Positive Phase I Data for Investigational Drug RAD1901 at the San Antonio Breast Cancer Symposium (SABCS) 2016

-3 patients had confirmed partial responses by RECIST criteria from ongoing Phase I studies with RAD1901 in patients with advanced estrogen receptor positive breast cancer- -In the Phase 1...
November 03, 2016 06:30 ET | Source: Radius Health Inc.

Radius Health Reports Third Quarter 2016 Financial and Operating Results

ACTIVE Phase 3 trial results published in Journal of American Medical Association and Journal of Bone Mineral ResearchRadius to present three abstracts on RAD1901 at San Antonio Breast Cancer...
November 01, 2016 18:18 ET | Source: Radius Health Inc.

Radius Health to Present at the Credit Suisse 25th Annual Healthcare Conference

WALTHAM, Mass., Nov. 01, 2016 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq:RDUS), a science-driven biopharmaceutical company that is committed to developing innovative therapeutics in the areas...
October 12, 2016 07:00 ET | Source: Radius Health Inc.

Radius Health to Announce Third Quarter 2016 Financial Results, Host Conference Call and Live Webcast on November 3, 2016

WALTHAM, Mass., Oct. 12, 2016 (GLOBE NEWSWIRE) -- Radius Health (Nasdaq:RDUS) announced today that it will release its third quarter 2016 financial results on Thursday, November 3, 2016. In...
September 19, 2016 13:00 ET | Source: Radius Health Inc.

Radius Presents Abaloparatide Transdermal Patch Development Program at American Society for Bone and Mineral Research (ASBMR) 2016 Annual Meeting

-Second Generation Transdermal Patch Achieves Pharmacokinetic Objectives– WALTHAM, Mass., Sept. 19, 2016 (GLOBE NEWSWIRE) -- Radius Health Inc. (Nasdaq:RDUS) a science-driven biopharmaceutical...
September 18, 2016 07:30 ET | Source: Radius Health Inc.

Radius Announces Publication of Additional Positive Results from the Phase 3 ACTIVE Trial of Abaloparatide-SC in JBMR

WALTHAM, Mass., Sept. 18, 2016 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq:RDUS), a science-driven biopharmaceutical company that is committed to developing innovative therapeutics in the...